The average one-year price target for Stalprodukt (WSE:STP) has been revised to PLN373.73 / share. This is an increase of 11.77% from the prior estimate of PLN334.37 dated September 27, 2025. The ...
The average one-year price target for Stalprodukt (WSE:STP) has been revised to PLN329.20 / share. This is a decrease of 11.91% from the prior estimate of PLN373.73 dated November 14, 2025. The price ...
Sirnaomics Ltd. has completed IND-enabling studies for STP-125G, a single-stranded siRNA therapeutic targeting apolipoprotein C3 (ApoC3), based on its proprietary Galahead mxRNA technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback